Vanda Pharmaceuticals Valuation
| VNDA Stock | USD 5.19 0.21 4.22% |
At this time, the company appears to be fairly valued. Vanda Pharmaceuticals has a current Real Value of $5.23 per share. The regular price of the company is $5.19. Our model measures the value of Vanda Pharmaceuticals from inspecting the company fundamentals such as Shares Outstanding of 58.31 M, operating margin of (0.23) %, and Return On Equity of -0.0302 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Vanda Pharmaceuticals' valuation include:
Price Book 0.5365 | Enterprise Value -77.9 M | Enterprise Value Ebitda 12.9072 | Price Sales 1.5856 | Forward PE 30.303 |
Fairly Valued
Today
Please note that Vanda Pharmaceuticals' price fluctuation is slightly risky at this time. Calculation of the real value of Vanda Pharmaceuticals is based on 3 months time horizon. Increasing Vanda Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Vanda Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vanda Stock. However, Vanda Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.19 | Real 5.23 | Target 5.4 | Hype 5.19 |
The real value of Vanda Stock, also known as its intrinsic value, is the underlying worth of Vanda Pharmaceuticals Company, which is reflected in its stock price. It is based on Vanda Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Vanda Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Vanda Pharmaceuticals helps investors to forecast how Vanda stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vanda Pharmaceuticals more accurately as focusing exclusively on Vanda Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Vanda Pharmaceuticals' intrinsic value based on its ongoing forecasts of Vanda Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Vanda Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Vanda Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Vanda Pharmaceuticals Cash |
|
Vanda Valuation Trend
Comparing Vanda Pharmaceuticals' enterprise value against its market capitalization is a good way to estimate the value of Vanda Pharmaceuticals uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Vanda Revenue by Product
Vanda Pharmaceuticals Total Value Analysis
Vanda Pharmaceuticals is at this time forecasted to have valuation of (77.95 M) with market capitalization of 314.86 M, debt of 9.4 M, and cash on hands of 440.86 M. The negative valuation of Vanda Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Vanda Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(77.95 M) | 314.86 M | 9.4 M | 440.86 M |
Vanda Pharmaceuticals Investor Information
About 77.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.54. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vanda Pharmaceuticals recorded a loss per share of 0.19. The entity had not issued any dividends in recent years. Based on the key indicators related to Vanda Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Vanda Pharmaceuticals is performing exceptionally good at this time. It has a great odds to report excellent financial results in December.Vanda Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Vanda Pharmaceuticals has an asset utilization ratio of 29.71 percent. This suggests that the Company is making $0.3 for each dollar of assets. An increasing asset utilization means that Vanda Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Vanda Pharmaceuticals Ownership Allocation
Vanda Pharmaceuticals shows a total of 58.31 Million outstanding shares. The majority of Vanda Pharmaceuticals outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Vanda Pharmaceuticals to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Vanda Pharmaceuticals. Please pay attention to any change in the institutional holdings of Vanda Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Vanda Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 192.64 M. Net Income was 2.51 M with profit before overhead, payroll, taxes, and interest of 230.1 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Vanda Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Vanda Pharmaceuticals and how it compares across the competition.
About Vanda Pharmaceuticals Valuation
The stock valuation mechanism determines Vanda Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Vanda Pharmaceuticals. We calculate exposure to Vanda Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vanda Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 192.6 M | 123.7 M | |
| Pretax Profit Margin | 0.03 | 0.03 | |
| Operating Profit Margin | (0.07) | (0.08) | |
| Net Profit Margin | 0.01 | 0.01 | |
| Gross Profit Margin | 0.92 | 0.69 |
Vanda Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 57.6 M | |
| Quarterly Earnings Growth Y O Y | -0.959 | |
| Forward Price Earnings | 30.303 |
Vanda Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Vanda Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Vanda we look at many different elements of the entity such as Vanda's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Vanda Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Vanda Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Vanda Pharmaceuticals' worth.Complementary Tools for Vanda Stock analysis
When running Vanda Pharmaceuticals' price analysis, check to measure Vanda Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vanda Pharmaceuticals is operating at the current time. Most of Vanda Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vanda Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vanda Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vanda Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |